Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hominis placenta pharmacopuncture is a therapeutic modality used in Korean Medicine that involves the injection of human placenta extract into specific acupoints or anatomical sites. The extract is derived from human placenta and contains a complex mixture of bioactive substances, including growth factors, cytokines, amino acids, vitamins, and minerals. It is utilized for its potential anti-inflammatory, regenerative, and hormonal regulatory properties. Clinical research has focused on its efficacy in managing perimenopausal and postmenopausal symptoms (such as hot flashes), musculoskeletal conditions like osteoarthritis, and cognitive disorders including mild cognitive impairment (MCI). The treatment combines the mechanical stimulation of acupuncture with the pharmacological effects of the placental biologic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on hominis placenta pharmacopuncture.